Beta-1 adrenergic receptor
Details
- Name
- Beta-1 adrenergic receptor
- Kind
- protein
- Synonyms
- ADRB1R
- B1AR
- Beta-1 adrenoceptor
- Beta-1 adrenoreceptor
- Gene Name
- ADRB1
- UniProtKB Entry
- P08588Swiss-Prot
- Organism
- Humans
- NCBI Taxonomy ID
- 9606
- Amino acid sequence
>lcl|BSEQ0055676|Beta-1 adrenergic receptor MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAG MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVV WGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVC TVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIM AFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAP LANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFV FFNWLGYANSAFNPIIYCRSPDFRKAFQGLLCCARRAARRRHATHGDRPRASGCLARPGP PPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
- Number of residues
- 477
- Molecular Weight
- 51222.97
- Theoretical pI
- 9.03
- GO Classification
- Functionsalpha-2A adrenergic receptor binding / beta-adrenergic receptor activity / beta1-adrenergic receptor activity / PDZ domain binding / protein heterodimerization activityProcessesadenylate cyclase-activating adrenergic receptor signaling pathway / brown fat cell differentiation / diet induced thermogenesis / fear response / heat generation / negative regulation of multicellular organism growth / positive regulation of heart rate by epinephrine-norepinephrine / positive regulation of the force of heart contraction by epinephrine-norepinephrine / response to coldComponentsearly endosome / plasma membrane
- General Function
- Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling. Involved in the regulation of sleep/wake behaviors (PubMed:31473062)
- Specific Function
- alpha-2A adrenergic receptor binding
- Pfam Domain Function
- 7tm_1 (PF00001)
- Signal Regions
- Not Available
- Transmembrane Regions
- 56-84 94-120 133-154 173-196 223-248 320-349 355-377
- Cellular Location
- Cell membrane
- Gene sequence
>lcl|BSEQ0010189|Beta-1 adrenergic receptor (ADRB1) ATGGGCGCGGGGGTGCTCGTCCTGGGCGCCTCCGAGCCCGGTAACCTGTCGTCGGCCGCA CCGCTCCCCGACGGCGCGGCCACCGCGGCGCGGCTGCTGGTGCCCGCGTCGCCGCCCGCC TCGTTGCTGCCTCCCGCCAGCGAAAGCCCCGAGCCGCTGTCTCAGCAGTGGACAGCGGGC ATGGGTCTGCTGATGGCGCTCATCGTGCTGCTCATCGTGGCGGGCAATGTGCTGGTGATC GTGGCCATCGCCAAGACGCCGCGGCTGCAGACGCTCACCAACCTCTTCATCATGTCCCTG GCCAGCGCCGACCTGGTCATGGGGCTGCTGGTGGTGCCGTTCGGGGCCACCATCGTGGTG TGGGGCCGCTGGGAGTACGGCTCCTTCTTCTGCGAGCTGTGGACCTCAGTGGACGTGCTG TGCGTGACGGCCAGCATCGAGACCCTGTGTGTCATTGCCCTGGACCGCTACCTCGCCATC ACCTCGCCCTTCCGCTACCAGAGCCTGCTGACGCGCGCGCGGGCGCGGGGCCTCGTGTGC ACCGTGTGGGCCATCTCGGCCCTGGTGTCCTTCCTGCCCATCCTCATGCACTGGTGGCGG GCGGAGAGCGACGAGGCGCGCCGCTGCTACAACGACCCCAAGTGCTGCGACTTCGTCACC AACCGGGCCTACGCCATCGCCTCGTCCGTAGTCTCCTTCTACGTGCCCCTGTGCATCATG GCCTTCGTGTACCTGCGGGTGTTCCGCGAGGCCCAGAAGCAGGTGAAGAAGATCGACAGC TGCGAGCGCCGTTTCCTCGGCGGCCCAGCGCGGCCGCCCTCGCCCTCGCCCTCGCCCGTC CCCGCGCCCGCGCCGCCGCCCGGACCCCCGCGCCCCGCCGCCGCCGCCGCCACCGCCCCG CTGGCCAACGGGCGTGCGGGTAAGCGGCGGCCCTCGCGCCTCGTGGCCCTGCGCGAGCAG AAGGCGCTCAAGACGCTGGGCATCATCATGGGCGTCTTCACGCTCTGCTGGCTGCCCTTC TTCCTGGCCAACGTGGTGAAGGCCTTCCACCGCGAGCTGGTGCCCGACCGCCTCTTCGTC TTCTTCAACTGGCTGGGCTACGCCAACTCGGCCTTCAACCCCATCATCTACTGCCGCAGC CCCGACTTCCGCAAGGCCTTCCAGGGACTGCTCTGCTGCGCGCGCAGGGCTGCCCGCCGG CGCCACGCGACCCACGGAGACCGGCCGCGCGCCTCGGGCTGTCTGGCCCGGCCCGGACCC CCGCCATCGCCCGGGGCCGCCTCGGACGACGACGACGACGATGTCGTCGGGGCCACGCCG CCCGCGCGCCTGCTGGAGCCCTGGGCCGGCTGCAACGGCGGGGCGGCGGCGGACAGCGAC TCGAGCCTGGACGAGCCGTGCCGCCCCGGCTTCGCCTCGGAATCCAAGGTGTAG
- Chromosome Location
- 10
- Locus
- 10q25.3
- External Identifiers
Resource Link UniProtKB ID P08588 UniProtKB Entry Name ADRB1_HUMAN GenBank Protein ID 178200 GenBank Gene ID J03019 GeneCard ID ADRB1 GenAtlas ID ADRB1 HGNC ID HGNC:285 PDB ID(s) 2LSQ, 7BTS, 7BU6, 7BU7, 7BVQ KEGG ID hsa:153 IUPHAR/Guide To Pharmacology ID 28 NCBI Gene ID 153 - General References
- Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK: Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7920-4. [Article]
- Moore JD, Mason DA, Green SA, Hsu J, Liggett SB: Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C. Hum Mutat. 1999 Sep 19;14(3):271. [Article]
- Deloukas P, Earthrowl ME, Grafham DV, Rubenfield M, French L, Steward CA, Sims SK, Jones MC, Searle S, Scott C, Howe K, Hunt SE, Andrews TD, Gilbert JG, Swarbreck D, Ashurst JL, Taylor A, Battles J, Bird CP, Ainscough R, Almeida JP, Ashwell RI, Ambrose KD, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Bates K, Beasley H, Bray-Allen S, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Cahill P, Camire D, Carter NP, Chapman JC, Clark SY, Clarke G, Clee CM, Clegg S, Corby N, Coulson A, Dhami P, Dutta I, Dunn M, Faulkner L, Frankish A, Frankland JA, Garner P, Garnett J, Gribble S, Griffiths C, Grocock R, Gustafson E, Hammond S, Harley JL, Hart E, Heath PD, Ho TP, Hopkins B, Horne J, Howden PJ, Huckle E, Hynds C, Johnson C, Johnson D, Kana A, Kay M, Kimberley AM, Kershaw JK, Kokkinaki M, Laird GK, Lawlor S, Lee HM, Leongamornlert DA, Laird G, Lloyd C, Lloyd DM, Loveland J, Lovell J, McLaren S, McLay KE, McMurray A, Mashreghi-Mohammadi M, Matthews L, Milne S, Nickerson T, Nguyen M, Overton-Larty E, Palmer SA, Pearce AV, Peck AI, Pelan S, Phillimore B, Porter K, Rice CM, Rogosin A, Ross MT, Sarafidou T, Sehra HK, Shownkeen R, Skuce CD, Smith M, Standring L, Sycamore N, Tester J, Thorpe A, Torcasso W, Tracey A, Tromans A, Tsolas J, Wall M, Walsh J, Wang H, Weinstock K, West AP, Willey DL, Whitehead SL, Wilming L, Wray PW, Young L, Chen Y, Lovering RC, Moschonas NK, Siebert R, Fechtel K, Bentley D, Durbin R, Hubbard T, Doucette-Stamm L, Beck S, Smith DR, Rogers J: The DNA sequence and comparative analysis of human chromosome 10. Nature. 2004 May 27;429(6990):375-81. [Article]
- Pak Y, Pham N, Rotin D: Direct binding of the beta1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation. Mol Cell Biol. 2002 Nov;22(22):7942-52. [Article]
- He J, Bellini M, Xu J, Castleberry AM, Hall RA: Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression. J Biol Chem. 2004 Nov 26;279(48):50190-6. Epub 2004 Sep 9. [Article]
- Cheng SB, Quinn JA, Graeber CT, Filardo EJ: Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J Biol Chem. 2011 Jun 24;286(25):22441-55. doi: 10.1074/jbc.M111.224071. Epub 2011 May 2. [Article]
- Mason DA, Moore JD, Green SA, Liggett SB: A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999 Apr 30;274(18):12670-4. [Article]
- Borjesson M, Magnusson Y, Hjalmarson A, Andersson B: A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J. 2000 Nov;21(22):1853-8. [Article]
- Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N: A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet. 2002 Apr;70(4):935-42. Epub 2002 Feb 18. [Article]
Associated Data
- Drug Relations
Drug Drug group Pharmacological action? Type Actions Details Esmolol approved, withdrawn yes target antagonist Details Betaxolol approved, investigational yes target antagonist Details Isoetharine approved yes target agonist Details Metoprolol approved, investigational yes target antagonist Details Atenolol approved yes target antagonist Details Timolol approved yes target antagonist Details Propranolol approved, investigational yes target antagonist Details Bisoprolol approved yes target antagonist Details Dobutamine approved yes target agonist Details Alprenolol experimental, withdrawn yes target antagonist Details Pindolol approved, investigational yes target partial agonist Details Isoprenaline approved, investigational yes target agonist Details Arbutamine approved yes target agonist Details Acebutolol approved, investigational yes target partial agonist Details Nadolol approved yes target antagonist Details Levobunolol approved yes target antagonist Details Metipranolol approved yes target antagonist Details Carteolol approved yes target antagonistpartial agonist Details Labetalol approved yes target antagonist Details Epinephrine approved, vet_approved yes target agonist Details Carvedilol approved, investigational yes target antagonist Details Desipramine approved, investigational unknown target other Details Bevantolol experimental yes target antagonist Details Practolol approved yes target antagonist Details Oxprenolol approved yes target antagonist Details Penbutolol approved, investigational yes target antagonistpartial agonist Details Norepinephrine approved yes target agonist Details Dronedarone approved unknown target antagonist Details Nebivolol approved, investigational yes target antagonist Details Droxidopa approved, investigational yes target agonist Details PW2101 investigational unknown target Details Albuterol approved, vet_approved unknown target agonist Details Sotalol approved yes target antagonist Details Pirbuterol approved unknown target agonist Details Fenoterol approved, investigational unknown target agonist Details Phenylpropanolamine approved, vet_approved, withdrawn unknown target agonist Details Clenbuterol approved, investigational, vet_approved unknown target agonist Details 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile experimental unknown target Details 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL experimental unknown target Details Bopindolol experimental yes target antagonistpartial agonist Details Bupranolol experimental yes target antagonist Details Pseudoephedrine approved unknown target agonistpartial agonist Details Celiprolol approved, investigational yes target antagonist Details Ephedra sinica root nutraceutical yes target agonist Details Asenapine approved unknown target antagonist Details Loxapine approved unknown target binder Details Cabergoline approved unknown target binder Details Vortioxetine approved, investigational unknown target ligand Details Befunolol experimental unknown target Details Formoterol approved, investigational unknown target agonist Details Salmeterol approved unknown target inverse agonist Details Terbutaline approved unknown target antagonist Details Putrescine experimental unknown target Details Spermidine experimental unknown target Details Spermine experimental, nutraceutical unknown target Details Propafenone approved unknown target antagonist Details Levobetaxolol approved, investigational yes target antagonist Details Xamoterol approved yes target partial agonist Details Arotinolol investigational yes target antagonist Details Lamotrigine approved, investigational unknown target inhibitor Details Racepinephrine approved yes target agonist Details DL-Methylephedrine approved yes target agonist Details Ranolazine approved, investigational no target antagonist Details Aripiprazole approved, investigational unknown target ligand Details Ephedrine approved yes target agonist Details Mirabegron approved unknown target agonist Details Iloperidone approved unknown target antagonist Details Bethanidine approved yes target antagonist Details Dichloroisoproterenol investigational yes target inhibitor Details Bucindolol investigational yes target modulator Details Bretylium approved yes target antagonist Details Dipivefrin approved yes target antagonist Details Anisodamine investigational yes target modulator Details Raubasine experimental yes target modulator Details Protokylol approved, vet_approved yes target modulator Details